CHINA NATURAL RESOURCES INC (CHNR)

VGG2110U1176 - Common Stock

0.8081  +0.08 (+11.68%)

After market: 0.7993 -0.01 (-1.09%)

Fundamental Rating

0

Overall CHNR gets a fundamental rating of 0 out of 10. We evaluated CHNR against 157 industry peers in the Metals & Mining industry. CHNR may be in some trouble as it scores bad on both profitability and health. CHNR does not seem to be growing, but still is valued expensively.



1

1. Profitability

1.1 Basic Checks

In the past year CHNR has reported negative net income.
In the past year CHNR has reported a negative cash flow from operations.
In the past 5 years CHNR reported 4 times negative net income.
CHNR had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

CHNR has a Return On Assets of -6.56%. This is in the lower half of the industry: CHNR underperforms 66.88% of its industry peers.
CHNR's Return On Equity of -65.92% is on the low side compared to the rest of the industry. CHNR is outperformed by 85.35% of its industry peers.
Industry RankSector Rank
ROA -6.56%
ROE -65.92%
ROIC N/A
ROA(3y)-5.85%
ROA(5y)-123.23%
ROE(3y)-28.91%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Gross Margin of CHNR (32.53%) is better than 76.43% of its industry peers.
CHNR's Gross Margin has improved in the last couple of years.
CHNR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y41.01%
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

CHNR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CHNR has more shares outstanding
CHNR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CHNR has been reduced compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of -1.30, we must say that CHNR is in the distress zone and has some risk of bankruptcy.
CHNR has a Altman-Z score of -1.30. This is amonst the worse of the industry: CHNR underperforms 87.90% of its industry peers.
CHNR has a Debt/Equity ratio of 1.24. This is a high value indicating a heavy dependency on external financing.
CHNR has a worse Debt to Equity ratio (1.24) than 90.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF N/A
Altman-Z -1.3
ROIC/WACCN/A
WACC8.69%

2.3 Liquidity

A Current Ratio of 0.62 indicates that CHNR may have some problems paying its short term obligations.
CHNR has a Current ratio of 0.62. This is amonst the worse of the industry: CHNR underperforms 92.36% of its industry peers.
A Quick Ratio of 0.61 indicates that CHNR may have some problems paying its short term obligations.
CHNR's Quick ratio of 0.61 is on the low side compared to the rest of the industry. CHNR is outperformed by 86.62% of its industry peers.
Industry RankSector Rank
Current Ratio 0.62
Quick Ratio 0.61

0

3. Growth

3.1 Past

CHNR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -106.83%.
CHNR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -52.83%.
CHNR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -48.34% yearly.
EPS 1Y (TTM)-106.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-645.97%
Revenue 1Y (TTM)-52.83%
Revenue growth 3Y-48.33%
Revenue growth 5YN/A
Sales Q2Q%-24.12%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

CHNR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CHNR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CHINA NATURAL RESOURCES INC

NASDAQ:CHNR (10/11/2024, 8:00:00 PM)

After market: 0.7993 -0.01 (-1.09%)

0.8081

+0.08 (+11.68%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap7.98M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.56%
ROE -65.92%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 32.53%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.62
Quick Ratio 0.61
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-106.83%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-52.83%
Revenue growth 3Y-48.33%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y